So the stock is attached to a real, maturing franchise. The question is what the mRNA platform is worth, and the honest ...
National Cancer Institute’s director, Dr. Anthony Letai, wants a national effort behind the vaccines, The New York Times ...
A new mRNA flu vaccine promises a closer match to circulating flu strains. But dysfunction at federal health agencies is ...
Health Secretary Robert F. Kennedy Jr. announced a department-wide effort Thursday to study and treat possible vaccine ...
A new review synthesizes preclinical and clinical evidence showing that lipid nanoparticle biodistribution, mRNA persistence, ...
Iowa’s vaccine policy is up for debate in the hotly contested governor’s race, with the two candidates on the ballot ...
Some of the latest research frontiers are investigating the idea of “cancer vaccines” and other so-called targeted treatments ...
4 COVID-19 vaccines took a record nine months to develop. The international scientific community coordinated by the Coalition for Epidemic Preparedness Innovations (CEPI), which Singapore is part of, ...
Flusiva is an mRNA vaccine created by Moderna. The U.S. Food and Drug Administration approved it for adults 50 and older in ...
Dan Costin, MD, discusses where personalized mRNA vaccines could fit into lung cancer care within 5 to 10 years. Dan Costin, ...
With all the dire predictions about AI's potential to wipe out humanity, today we highlight two studies that use the ...
With all the dire predictions about AI's potential to wipe out humanity, today we highlight two studies that use the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results